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Abstract
Intercellular communication plays an essential role in the (patho)physiological func-
tion of the adipose tissue. (pre)adipocyte-secreted proteins, collectively known as 
adipokines, serve as signaling molecules in a paracrine and endocrine fashion. adipo-
kine profiles are dynamic and can change dramatically leading to metabolic complica-
tions during obesity or can return towards a more beneficial profile under influence of 
weight loss interventions. here it is reviewed how proteomics technologies contrib-
uted to identify (pre)adipocyte-secreted proteins. Different secretion routes are high-
lighted with a particular focus on microvesicle-mediated secretion. Furthermore, novel 
information is provided on identification of human adipokines and on the application 
of proteomics technologies to discover unknown adipokine-receptor interactions.
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introduction
Cellular communication is essential in 
the function of organs and complete 
organisms. It is predicted that 10-15% 
of the eukaryotic proteome consists 
of secretory proteins (1). Changes in 
the profiles of secreted proteins have 
profound effects on inter-organ sign-
aling and may lead to pathophysi-
ological conditions. The adipose tis-
sue has been recognized as a dynamic 
secretory organ that releases proteins, 
known as adipokines, which affect 
neighbor cells in the adipose tissue 
(paracrine factors) or target cells from 
other organs after they have entered 
the blood stream (endocrine factors). 
Adipokines secreted from (pre)adi-
pocytes serve as signaling molecules 
in normal physiology (2). However, 
a deregulation of the adipose tissue 
during obesity results in changed adi-
pokine profiles, which is associated 
with the development of the meta-
bolic syndrome (3-5). Conversely, 
interventions with caloric restriction 
and potential health beneficial com-
pounds mimicking caloric restriction 
change the adipokine profile towards 
a more healthy status (Rosenow et al, 
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in press). 
The present article describes how proteomics research has 
contributed to adipokine research by discovery of novel adi-
pokines and by monitoring changes in adipokine profiles during 
interventions. Furthermore, considering the emerging questions 
how adipokines communicate with other cells, it is briefly dis-
cussed how proteomics technologies may aid to discover novel 
adipokine-receptor interactions and as such gain more insight 
in the (patho)physiological functions of (human) adipokines.
the need for proteomics research to investigate adipo-
cyte-secreted proteins
One might ask: Why is proteomics technology important for 
adipokine research? Large-scale investigation of gene expres-
sion by DNA microarray has entered the phase of routine-like 
research. Also in adipobiology this technology has been applied 
for several gene expression studies (6-9). However, particularly 
in mammalian systems, the correlation between protein and 
gene expression is low (9-11). As a consequence, independent 
protein expression is required to gain a further understanding 
of the molecular events in cells and tissues. Particularly with 
respect to large-scale secretome studies, including adipokine 
profiling, one needs technologies to capture, analyze and iden-
tify proteins since levels of secreted proteins often do not par-
allel the expression levels of associated genes. As an example, 
we previously investigated adipocyte-secreted proteins upon 
insulin stimulation (12). In the same study we also measured 
mRNA expression levels of secreted proteins. From 29 identified 
secreted proteins that were regulated by insulin only 4 showed a 
comparable regulation at the mRNA level. Instead, many genes 
induced by insulin coded for processing enzymes involved in 
post-translational modifications and specific proteolytic events 
that all play a role in the protein secretion process. This demon-
strates that gene expression analysis on the mRNA level is insuf-
ficient to identify changes in the adipocyte secretome but on the 
other hand it also showed that a combination of mRNA and pro-
tein analysis provided a better understanding of the mechanism 
how insulin regulated the observed adipokine changes. 
Another reason why protein technologies are required to in-
vestigate secretome changes is that secretory proteins can also 
be stored in granules inside the cell, which fuse with the plasma 
membrane and expose their contents upon particular stimuli (13-
15) or are secreted as microvesicles (16). As such, investigating 
mRNA expression of genes encoding for these proteins cannot re-
liably monitor protein secretion mediated by these export routes.
pathways for adipokine secretion 
The classical secretion route for proteins containing a N-termi-
nal or internal secretion signal peptide is the endoplasmic retic-
ulum (ER)-Golgi pathway (17). However, this does not exclude 
the secretion of proteins without a secretion signal peptide. The 
discovery of protein secretion from cells without a functional 
ER-Golgi system (18) started the search for alternative secre-
tion mechanisms. This revealed at least four additional secretion 
routes in eukaryotic cells that by-pass the Golgi system. These 
are (i) translocation of proteins to the extracellular space via 
transmembrane transport proteins, (ii) capture of proteins in se-
cretory lysosomes that subsequently fuse with the plasma mem-
brane and release their cargo, (iii) capture of proteins in intracel-
lular multivesicular bodies which are released as exosomes, and 
(iv) capture of proteins in vesicles budding from the cell surface 
(Fig. 1), for review see (16). As such, focusing on signal peptide 
features in the sequence of identified proteins will only cover 
part of the total secretome.
Strategies to identify adipocyte-secreted proteins
Still, since many secretory proteins are released from the cell by 
the classical pathway using the Golgi system, it is fairly easy to 
discriminate classically secreted proteins from non-classically 
secreted proteins by using brefeldin A (BFA). BFA is a com-
pound that blocks transport of Golgi-derived vesicles towards 
the plasma membrane (19). Other secretion pathways can be 
blocked by lowering the temperature to 20˚C (20). Our group 
used these blocking strategies to discriminate truly secreted 
proteins from proteins derived from cell leakage in mouse (21) 
and human (pre)adipocytes (22). Particularly with in vitro and 
ex vivo studies using cell cultures and tissue explants, leakage 
of intracellular non-secretory proteins by cellular damage may 
occur which can lead to false-positive results. The advantage of 
current sensitive proteomics technologies, as reviewed in (23), 
is that many proteins present in cellular medium can be identi-
fied.  Without the application of a blocking strategy a distinction 
between genuine secretory proteins and cell leakage proteins 
cannot be given solely based on the protein identifications. Ad-
ditional validation is required. Secretion features of identified 
proteins can be deduced from dedicated prediction servers such 
as SignalP and SecretomeP (Center for Biological Sequence 
Analysis, Technical University Denmark; http://www.cbs.dtu.
dk/services/). SignalP predicts the presence and location of sig-
nal peptide cleavage sites in amino acid sequences (24), while 
SecretomeP predicts non-classical, in particular non-signal 
peptide-triggered, protein secretion (25). In this process pro-
teins without a distinct signal peptide feature are screened for 
various post-translational and localizational aspects, which are 
integrated into a final secretion prediction. We applied SignalP 
to validate our BFA experiments performed with 2-dimensional 
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electrophoresis (2-DE) and it classified all proteins as classical 
secreted proteins. Furthermore, by using a combined SignalP 
and SecretomeP analysis we determined 78 secretory proteins 
out of 157 identified proteins from adipocyte medium that was 
analyzed by sensitive liquid chromatography tandem mass spec-
trometry (LC-MS/MS) (22). This suggests that the remaining 79 
proteins can be considered as non-secreted, cell leakage, pro-
teins. As stated before, with cell culture experiments one should 
always be aware of cell leakage proteins when targeting secretory 
proteins, particularly when a blocking strategy has been used. 
However, since microvesicles have been accepted as a genuine 
secretion mechanism, it became evident that proteins without 
any secretion feature can also be released into the extracellular 
space. 
Secretion by (pre)adipocyte-derived microvesicles
Microvesicle-mediated intercellular communication was al-
ready proposed in 1984 (26). Only recently it was shown that 
(pre)adipocytes also secrete proteins via microvesicles, which 
have been referred to as adiposomes (27). Microvesicles have 
long been considered as artifacts within cell culture systems. 
Nowadays, microvesicles are recognized as important com-
munication particles involved in coagulation, inflammatory 
responses and tumor progression by mediating intercellular 
transport of specific proteins and even mRNA and microRNA 
(28). The name microvesicles is the collective term for exosomes 
(diameter 40-100 nm) derived from intracellular multivesicular 
bodies and vesicles generated from direct budding of the plasma 
membrane (diameter up to 1 mm). Considering (pre)adipocyte-
derived microvesicles, there is no conclusive evidence yet about 
the origin of these vesicles. The diameter of the isolated vesicles 
was diverse, ranging from nm  to mm, as observed by electron 
microscopy (27). This suggests that they may have derived both 
from intracellular exosomes as well as from membrane budding. 
Nevertheless, microvesicles form a significant signaling route 
for (pre)adipocytes since they are involved in paracrine (29) and 
endocrine (30) communication. Müller et al (29) showed that 
microvesicles released from large donor rat adipocytes harbor-
ing glycosylphosphatidylinosotol-anchored proteins contain 
specific microRNA’s and are able to induce a lipogenic response 
in small acceptor rat adipocytes. An increased formation of adi-
pocyte-derived microvesicles was observed when donor adipo-
cytes were challenged with the lipogenic stimuli palmitate, the 
anti-diabetic drug glimepiride or H2O2. Aoki et al (30) demon-
strated that 3T3-L1 adipocyte-derived microvesicles promoted 
angiogenesis in vivo in a mouse model and stimulated invasion 
and tube formation of human umbilical vein endothelial cells 
(HUVEC) in an in vitro culture system. 
A RNA analysis of 3T3-L1-derived microvesicles revealed 
about 7000 mRNA and 140 microRNA (31). Additional RT-PCR 
Figure 1. alternative secretion mechanisms by-passing the classical ER-golgi pathway. 1. Translocation of proteins through 
the plasma membrane via transmembrane transport proteins. 2. capture of proteins in secretory lysosomes that subsequently 
fuse with the plasma membrane. 3. capture of proteins in intracellular multivesicular bodies that are subsequently released as 
exosomes. 4. protein packaging in vesicles that bud from the cell surface. pm, plasma membrane; golgi, golgi apparatus; ER, 
endoplasmic reticulum.
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confirmed the presence of intact polyadenylated RNA, includ-
ing leptin, adiponectin and PPARg-2 (31) but did not reveal the 
presence of CD73, Gce-1, perilipin-A and ß-actin (32). Treat-
ment of the microvesicles with the detergent Triton X-100 (31) 
or with ultrasonification (29) resulted in almost a complete loss 
of RNA and a strong reduction in the lipogenic response in ac-
ceptor adipocytes, respectively. These results suggest that only 
a subset of functional adipocyte-specific transcripts is incorpo-
rated into adipocyte-derived microvesicles. It was shown that 
adipocyte-derived microvesicles induce adiponectin and resis-
tin mRNA expression in mouse RAW264.7 macrophages (30). 
However, the physical presence of (pre)adipocyte-derived RNA 
molecules and proteins in targeted cells has not been proven yet 
as was done before for microvesicle-mediated intercellular com-
munication between mouse and human mast cells (33) and  hu-
man glioblastoma and human brain microvascular endothelial 
cells (34). 
In general, the question remains how microvesicles spe-
cifically recognize their target cells and how they interact with 
those. Currently, several different mechanisms are considered: 
(i) receptor-mediated interaction in a juxtacrine fashion, (ii) di-
rect fusion of the microvesicle with the target cell’s plasma mem-
brane, (iii) receptor-mediated interaction followed by mem-
brane fusion, and (iv) receptor-mediated interaction followed 
by internalization via endocytosis (Fig. 2) (28). Particularly the 
receptor-mediated interactions are considered for the specificity 
of target cell recognition, which argue for analysis of the protein 
composition of microvesicles derived from different cell types. 
Not only to analyze the membrane-bound proteins but also to 
identify the proteins present inside the lumen of the microvesi-
cle.  Proteomics technologies are particularly useful for this.
Proteome analysis of 3T3-L1-(pre)adipocyte-derived mi-
crovesicles has been performed, which revealed 98 different 
proteins, including cytoskeletal and cytosolic proteins (27). The 
protein composition of pre-adipocyte microvesicles differed 
from 10-day differentiated adipocyte microvesicles as was seen 
by increased amounts of heat shock protein 70, milk fat globule-
epidermal growth factor 8 (MFG-E8), adiponectin, caveolin-1 
and histone H2B in the latter ones. Furthermore, expression 
of MGF-E8 and caveolin-1 in microvesicles was induced upon 
treatment of adipocytes with either insulin (up to 1 mM) or tu-
mor necrosis factor-a (TNF-a) (up to 1 ng/ml). Transient over 
expression of adiponectin in HEK293 cells showed the presence 
of this protein in the cell lysate but not in microvesicles, sug-
gesting the selective association of adiponectin with adipocyte-
derived microvesicles (27). Together, this indicates a dynamic 
change in protein composition of microvesicles during preadi-
pocyte differentiation. In addition, the protein composition of 
Figure 2. proposed mechanisms for microvesicle interaction 
with their target cells.
1. microvesicles bind to target cell by receptor-mediated in-
teraction and elicit a signal transduction response. 2. Direct 
fusion of the microvesicle with the plasma membrane fol-
lowed by release of their cargo. 3. Receptor-mediated inter-
action followed by membrane fusion and cargo release. 4. 
Receptor-mediated interaction followed by internalization 
via endocytosis.
microvesicles appears to be selective. However, it should be not-
ed that an analysis of microvesicles from human (pre)adipocytes 
has not been reported yet. 
Comparison of the data from Aoki et al (27) with earlier 
3T3-L1 secretome studies revealed that only 27% (21) and 20% 
(35) of the previously identified proteins were represented in 
microvesicles. This suggests that (pre)adipocyte-derived mi-
crovesicles contain only a specific subset of the total secretome. 
As such, it would be highly interesting to know how the com-
position of microvesicles is determined. However, considering 
microvesicles in general, it is still unknown which intracellular 
mechanisms are involved that controls the accumulation of spe-
cific (cytosolic) proteins and RNA molecules inside the lumen of 
microvesicles. Still, since microvesicles contain a limited num-
ber of proteins known to be secreted from (pre)adipocytes, it 
remains important to consider the total secretome in order to 
understand how (pre)adipocytes communicate with other cells. 
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membrane protein shedding and extracellular matrix
An alternative way to release (truncated) proteins into the extra-
cellular space is proteolytic cleavage of transmembrane proteins. 
Particularly members of the matrix metalloproteinase (MMP) 
family are involved in this process (36). MMP are either secreted 
or are membrane bound and share the capacity to degrade all 
known transmembrane proteins (37) Several subtypes of these 
proteins have already been identified as secreted proteins from 
adipocytes (12,21,38), including MMP2 and MMP9, which are 
also present in 3T3-L1-derived microvesicles (27). MMP have 
long been considered primarily as modulators of the extracel-
lular matrix (ECM). However, increasing evidence has been 
provided that MMP are also involved in functional regulation 
of many non-ECM molecules such as cytokines, chemokines, 
growth factors, adhesion molecules, surface proteoglycans and 
several enzymes (39). Still, ECM proteins, including the colla-
gens which are often found in (pre)adipocyte secretomes, can 
also interact with cell surface receptors on target cells and elic-
it signal transduction responses (40). However, a direct proof 
whether MMP are actively involved in proteolysis of adipocyte-
bearing transmembrane proteins and as such stimulate secre-
tion from (pre)adipocytes has not been given yet. Though, it is 
striking to see that many ECM proteins, particularly collagens, 
and ECM-related proteins have been identified in (pre)adipo-
cyte secretome studies (reviewed in 41). It has been shown that 
ECM modulation is a feature of differentiating pre-adipocytes 
(21) and also mature adipocytes (42). In fact, ECM modula-
tion is a prerequisite for pre-adipocytes to allow lipid storage 
(41). As such, identification of ECM proteins and fragments of 
these in secretome studies may be a reflection of this process, 
which is probably (partly) controlled by the (pre)adipocytes 
own MMP. On the other hand, MMP-mediated degradation of 
ECM proteins (and other transmembrane proteins) is probably 
also important for the paracrine and endocrine function of (pre)
adipocytes. It remains an open question whether the proteolytic 
activity required for modulation of the (pre)adipocyte ECM 
and secretome comes from membrane-bound or microvesicle-
residing MMP.  With respect to (pre)adipocyte-secreted MMP 
it was shown that inhibition of MMP by 1,10’-phenanthroline 
strongly diminished the invasion capacity of HUVECs induced 
by 3T3-L1 adipocyte-derived microvesicles (30). A similar re-
sult was obtained with neutralizing antibodies against MMP2, 
but not with MMP9 antibodies. These results suggest that at 
least MMP2 in adipocyte-derived microvesicles stimulates the 
invasion potency of HUVECs. During angiogenesis invasion 
of endothelial cells is preceded by ECM remodeling. As such, 
adipocyte-derived microvesicles containing MMP may aid in 
this process.    
mouse versus human adipokines
Proteomics research has had a major impact on the identifica-
tion of novel adipokines. The first studies were performed with 
3T3-L1 cells (21,35) and demonstrated the applicability of pro-
teomics in adipokine research. In the last decade the applica-
tion of more advanced proteomics technologies gained popular-
ity in identifying (novel) adipokines. Currently, many different 
adipokines have already been identified from rodent and human 
origin by using different proteomics applications (2,43). How-
ever, it became clear that there is a considerable discrepancy 
between rodent and human adipokine expression in vivo. For 
instance, adipsin, an adipokine identified from mouse adipose 
tissue, showed decreased expression in obese mice and was orig-
inally thought to protect against obesity. In contrast, subsequent 
human studies failed to confirm this hypothesis and showed in-
creased adipsin levels in obese persons (44). In addition, TNF-a 
is expressed in mouse adipose tissue and is released into the cir-
culation, while in human it primarily acts locally in the adipose 
tissue (45). Even more contrasting is resistin that is produced in 
mouse adipose cells but not in human adipocytes (46). Together, 
these results show that, despite the value of mice studies, a one-
to-one extrapolation of data from mouse models to human adi-
pokine action is inexpedient. To speak with the words of Peter 
Arner with respect to adipokines: “Man are not mice” (47). It is 
therefore necessary to focus on human adipokines in order to 
understand the link between obesity and metabolic complica-
tions in man. 
proteomics and human adipokines
Proteomics technologies boosted the discovery of human adi-
pokines (43). Large sets of secreted proteins from human adi-
pose tissue have been identified with proteomics technology by 
using tissue explants from subcutaneous (48) and visceral fat 
(49). However, despite the valuable information obtained, the 
proteins obtained with this approach are derived from a mix-
ture of (pre)adipocytes and stromal vascular cells. Furthermore, 
it provides a static view on adipokine expression as it neglects 
the adipokine profile changes during preadipocyte hypertrophy. 
Consequently, with this approach it is hardly possible to de-
termine how preadipocyte hypertrophy is associated with adi-
pokine profile changes and how this may involve the initiation 
of metabolic complications like insulin resistance. For this one 
needs purified preadipocytes from subcutaneous and visceral fat 
depots to monitor the changes in adipokine profiles during dif-
ferentiation. 
Although primary human preadipocytes are commercially 
available they are limited in their propagation capacity and can-
not easily be manipulated. This lead to the search for alterna-
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tives, which revealed immortalized human adipocytes (50), 
human multipotent adipose-derived stem cells (hMADS) (51) 
and human Simpson Golabi Behmel Syndrome (SGBS) cells 
(52). SGBS cells are identical to subcutaneous adipocytes from 
healthy subjects with respect to morphology, biochemistry and 
functionality but, in contrast to primary adipocytes, they can 
be propagated for more than 30 generations without loosing 
their adipocyte characteristics. Furthermore, SGBS cells require 
serum-free conditions during differentiation, which prevents 
contamination of secreted adipokines with serum proteins. 
With these cells we identified 6 novel adipokines by using two 
different proteomics techniques. Furthermore, we found 20 adi-
pokines that had not been detected before in human adipose 
material. Finally, 23 additional adipokines, previously detected 
in visceral adipose tissue, were found secreted by our SGBS-cells 
of subcutaneous adipose tissue origin (22). 
As a follow-up we have investigated changes in SGBS adi-
pokine profiles under influence of hypoxia, starvation and res-
veratrol (RSV) treatment. RSV is a natural polyphenolic com-
pound found in over 70 plant species, but its presence in the skin 
of red grapes, and as such in red wine, gained its popularity (53). 
In the course of its postulated beneficial health effects and its 
proposed capacity to mimic caloric restriction we investigated 
the influence of RSV on SGBS adipokine profiles. We observed 
that RSV induced secretion of proteins that are protective against 
cellular stress and proteins that are involved in the regulation of 
apoptosis. Furthermore, we found a RSV-induced up-regulation 
of adiponectin and ApoE accompanied by a down-regulation of 
PAI-1 and pigment epithelium-derived factor (PEDF) secretion. 
This indicates that RSV can change the human adipocyte secre-
tion profile towards a more beneficial pattern that may improve 
the obesity-associated pro-inflammatory state, insulin sensitivi-
ty and thrombotic phenotype. Furthermore, two novel RSV-reg-
ulated adipocyte-secreted proteins were discovered (Rosenow et 
al. 2012, in press). As such, by using proteomics technologies 
we were able to monitor intervention effects on the adipokine 
profiles from human adipocytes.
Adipokine-receptor interactions
Although many (human) adipokines have been identified (43) 
their (patho)physiological significance remains poorly under-
stood. Consequently, there is considerable interest in which adi-
pokines communicate with other cells and how they are involved 
in the initiation of the obesity-induced metabolic syndrome. For 
this a novel approach is being developed in our laboratory. I es-
tablished a novel method to identify (un)known adipokine-re-
ceptor interactions by using UV-mediated cross-linking (Renes 
et al. in preparation). Upon UV-irradiation 3 model adipokines 
and 1 positive control, all labeled with fluorescent tags, cross-
linked to the cell surface of human HepG2 liver cells via a dedi-
cated photo-activatable cross-linker as observed by fluorescent 
confocal microscopy. With the same approach I observed cross-
linking of adipokines secreted from our SGBS cells to HepG2 
cells. These cross-linked complexes were isolated and separated 
by using a rather classical 2-DE protocol (54). 2-DE is required 
for this approach since intact protein complexes are difficult to 
separate by using more sophisticated LC-MS/MS. With the lat-
ter technique protein samples should be digested prior to sepa-
ration and as such intact single fluorescent complexes cannot be 
detected within a complex plasma membrane protein sample. 
By using 2-DE fluorescent spots indicating adipokine-receptor 
complexes were indeed observed among many unlabeled pro-
tein spots after scanning the gel. These single complexes were ex-
cised from the gel and subjected to mass spectrometry for iden-
tification, which revealed 3 receptor proteins and 12 secretory 
proteins. The receptor proteins have not been annotated before 
as adipokine receptor and are further validated. As such, this 
novel approach allows identification of (un)known adipokine-
receptor interactions. Furthermore, once established, the meth-
od is widely applicable in intercellular communication research. 
Conclusion and future perspectives
The proteomics technology, although being a set of research 
tools, contributed considerably towards a further dissection of 
the (pre)adipocyte secretome. By using different proteomics 
approaches already over 600 (pre)adipocyte-secreted proteins 
have been identified, including a notable number of novel ones. 
Furthermore, proteomics techniques are applicable to monitor 
effects of interventions on the (pre)adipocyte secretome and as 
such contribute to a further understanding of potential health 
beneficial effects of intervention studies. With the application of 
even more sensitive future mass spectrometry instruments the 
still incomplete characterized (pre)adipocyte secretome can be 
further analyzed. Though, even with the ongoing development 
in mass spectrometry, the “old-fashioned” 2-DE method is still a 
valuable approach to monitor adipokine-receptor interactions A 
new horizon in adipo-interactomics may thus be opened. 
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